ES2044959T3 - Exotoxina de tos ferina modificada. - Google Patents

Exotoxina de tos ferina modificada.

Info

Publication number
ES2044959T3
ES2044959T3 ES87311279T ES87311279T ES2044959T3 ES 2044959 T3 ES2044959 T3 ES 2044959T3 ES 87311279 T ES87311279 T ES 87311279T ES 87311279 T ES87311279 T ES 87311279T ES 2044959 T3 ES2044959 T3 ES 2044959T3
Authority
ES
Spain
Prior art keywords
subunit
exotoxin
toxin
cough
pertussis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87311279T
Other languages
English (en)
Inventor
William J Black
Stanley Falkow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25483606&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2044959(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Application granted granted Critical
Publication of ES2044959T3 publication Critical patent/ES2044959T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Secuencia de nucleótidos que comprende una información genética que codifica para la subunidad S1 de la proteína de la toxina de la tos ferina aislada delB. pertussis, en la que se ha modificado la secuencia para codificar para una subunidad S1 mutante de la toxina de la tos ferina, en la que el citado mutante de la subunidad S1 es capaz de una interacción con la subunidad B de la toxina de la tos ferina para formar una holotoxina, esta holotoxina no tiene la toxicidad de la toxina de la tos ferina de la cepa nativa pero presenta una inmunogenicidad protectora.
ES87311279T 1986-12-23 1987-12-22 Exotoxina de tos ferina modificada. Expired - Lifetime ES2044959T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US94583286A 1986-12-23 1986-12-23

Publications (1)

Publication Number Publication Date
ES2044959T3 true ES2044959T3 (es) 1994-01-16

Family

ID=25483606

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87311279T Expired - Lifetime ES2044959T3 (es) 1986-12-23 1987-12-22 Exotoxina de tos ferina modificada.

Country Status (6)

Country Link
EP (1) EP0275689B1 (es)
JP (1) JP2867374B2 (es)
AT (1) ATE80179T1 (es)
DE (1) DE3781541T2 (es)
ES (1) ES2044959T3 (es)
GR (1) GR3006444T3 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1202612B (it) * 1987-03-03 1989-02-09 Eniricerche Spa Plasmidi ricombinanti utili per l'espressione in bacillus di proteine eterologhe
KR0168039B1 (ko) * 1987-09-04 1999-01-15 로버트 디. 웨스트 재조합 dna에서 유도한 보르데텔라 외독소 소단위체의 유사체 및 그를 포함하는 백신
IT1223334B (it) * 1987-11-02 1990-09-19 Sclavo Spa Polipeptidi immunologicamente attivi con una tossicita' alterata utili per la preparazione di un vaccino antipertosse
GB8727489D0 (en) * 1987-11-24 1987-12-23 Connaught Lab Detoxification of pertussis toxin
US5332583A (en) * 1987-11-24 1994-07-26 Connaught Laboratories Limited Vaccine containing genetically-detoxified pertussis holotoxin
US5358868A (en) * 1987-11-24 1994-10-25 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
US5244657A (en) * 1987-11-24 1993-09-14 Connaught Laboratories Limited Genetic detoxification of pertussis toxin
FR2638169B1 (fr) * 1988-10-25 1991-01-11 Pasteur Institut Derives d'adenyl cyclase et leurs utilisations biologiques
US5786189A (en) * 1989-11-29 1998-07-28 Smithkline Beecham Biologicals (S.A.) Vaccine
FR2736064B1 (fr) 1995-06-30 1997-09-05 Pasteur Institut Epitopes protecteurs de l'adenyl cyclase-hemolysine(ac-hty). leur application au traitement ou a la prevention des infections par bordetella
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
CA2879939A1 (en) 2012-08-06 2014-02-13 Glaxosmithkline Biologicals S.A. Novel method
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
ES2597832T3 (es) 2013-03-08 2017-01-23 Janssen Vaccines & Prevention B.V. Vacuna acelular contra la tosferina
CA2919773A1 (en) 2013-08-05 2015-02-12 Glaxosmithkline Biologicals S.A. Combination immunogenic compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58146596A (ja) * 1982-02-25 1983-09-01 Takeda Chem Ind Ltd 組換えｄｎａ、それで形質転換させた微生物およびそれらの用途
GB8333131D0 (en) * 1983-12-12 1984-01-18 Glaxo Group Ltd Microbiological process
FR2590483B1 (fr) * 1985-11-22 1988-12-09 Pasteur Institut Antigenes purifies ayant des proprietes vaccinantes contre b. pertussis, moyens notamment adns recombinants pour les produire et compositions de vaccins les contenant
CA1340373C (en) * 1986-01-28 1999-02-02 Rino Rappuoli Cloning and sequencing of the dna fragment which codes for the five subunits of the pertussis toxin, a hybrid plasmid containing the dna fragment and micro-organisms transformed by the hybrid plasmid and capable of expressing all or some of the subunits of the pertussis toxin
US4883761A (en) * 1986-03-25 1989-11-28 The United States Of America As Represented By The Department Of Health And Human Services Pertussis toxin gene: cloning and expression of protective antigen

Also Published As

Publication number Publication date
JP2867374B2 (ja) 1999-03-08
DE3781541T2 (de) 1993-05-06
JPS63240789A (ja) 1988-10-06
EP0275689A1 (en) 1988-07-27
DE3781541D1 (de) 1992-10-08
GR3006444T3 (es) 1993-06-21
EP0275689B1 (en) 1992-09-02
ATE80179T1 (de) 1992-09-15

Similar Documents

Publication Publication Date Title
ES2044959T3 (es) Exotoxina de tos ferina modificada.
AR008508A1 (es) METODO PARA LOGRAR UNA EXPRESION ESPECíFICA MESoFILA DE UNA SECUENCIA DE NUCLEOTIDOS CODIFICANTE EN PLANTAS, CONTROLADA POR UN PROMOTOR , CASETES DE EXPRESION, VECTORES RECOMBINANTES Y MICROORGANISMOS QUE CONTIENEN DICHOS PROMOTORES, UTILIZACION DE DICHOS VECTORES Y PROMOTORES Y PROCEDIMIENTO PARA P
CY1106350T1 (el) Εμβολιο φυματιωσης
AR006999A1 (es) Una composición inmunogénica, terapéutica o profiláctica , que comprende un polipéptido omp106 aislado, un anticuerpo aislado que se liga a dicho polipéptido y una vacuna que lo comprende.
NO960839L (no) Bakterieeksporterte proteiner og acellulære vaksiner som er basert på disse
ES2054701T3 (es) Clonacion y expresion de dna conteniendo el codigo de la toxina bordetella pertussis.
NO851878L (no) Fremgangsmaate for isolering av antigeniske preparater.
ATE429929T1 (de) Verbesserte impfstoffe
DK0425082T3 (da) Vacciner
GB9409985D0 (en) Vaccine against mycobacterial infections
ES2170055T3 (es) Proteinas de mycobacterium y su aplicacion.
ATE346931T1 (de) Clostridium perfringens impfstoff
ES2053950T3 (es) Vacuna contra la coccidiosis.
GB9727512D0 (en) Fuzzy genes and their application in molecular adjuvants
ATE184787T1 (de) Therapeutische kombinationen
DK0463053T3 (da) Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
ES2060974T3 (es) Cepas de levadura para la produccion de proteinas heterologas maduras, en particular de hirudina.
AP8900132A0 (en) Bordetella pertussis vaccine
DK0427462T3 (da) Fremgangsmåde
ATE108481T1 (de) Neue bacillus thuringiensis-stämme.
DE69434087D1 (de) ENTEROTOXINE VON SHIGELLA FLEXNERI 2a
ES2053694T3 (es) Clonaje y secuenciacion del gen que codifica una nueva subunidad pilinica de bordetella pertussis.
DK0426059T3 (da) Promotorområder for generne der koder pilinunderenhederne fim2, fim3 og fimx af Bordetella pertussis, samt anvendelse deraf til ekspression af gener, der koder for et ønsket protein
ES2104130T3 (es) Adn hibrido, que codifica una subunidad de una toxina bacteriana con una hemolisina.
ES2072865T3 (es) Cepa bacteriana.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 275689

Country of ref document: ES